In this podcast, Laura Fabris, PhD, from Rutgers University, answers our questions about how her research team identified and quantified RNA mutations in the influenza A virus...
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.
Dr Cennimo discusses serious health complications that can arise from acquiring influenza virus, as well as vulnerable populations that are the most susceptible to these complications.
Patients with psoriasis and HIV comprise a unique subgroup that requires special consideration for treatment due to complications and comorbidities associated with both diseases, according to Wilson Liao,...
Patients with psoriasis and HIV comprise a unique subgroup that requires special consideration for treatment due to complications and comorbidities associated with both diseases, according to Wilson Liao,...
In this commentary, Michael B. Grosso, MD, writes about the history of vaccine hesitancy, how hesitancy has affected the use of the human papillomavirus vaccine, and what you can do to reduce hesitancy in...
In this Editorial, Shobha Swaminathan, MD, writes about the shift from desperation and fear regarding HIV/AIDS in the 1980s to optimism and hope today.
He talks about how specific vaccinations have benefitted our society, why some viruses can be eradicated while others cannot, and how misconceptions about the harms of vaccines started.
In this podcast, Evan Brickner and Trini Mathew, MD, MPH, discuss their latest research paper on evaluating for alcohol use disorder among patients with HIV in their primary care clinic, how other...
In this podcast, Andrew Halayko, PhD, ATSF, summarizes hot topics to be discussed at the American Thoracic Society (ATS) 2022 annual conference, including how COVID-19 has influenced the program agenda...
